Searched for
WINDLAS BIOTECH LISTING
Windlas Biotech rallies 19% on concluding EU inspection with zero critical observationThe recently listed pharmaceuticals player said it has concluded European Union's good manufacturing practice inspection carried out by the...- 2021 proves to be the best year for initial offerings and listingsThe year 2021 so far has been the best year for the initial public offerings (IPOs) and listings. Out of the 51 IPOs listed on the main exc...
- No IPO magic for CarTrade, loses 7.3% on debut dayThe shares that were issued at ₹1,618 each opened trading at ₹1,600 on the BSE and fell to a low of ₹1,476 in early trade before closing at...
- Devyani lists at 56% premium to IPO price, others witness muted debutsShares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...
- Biggest gainers & losers of the day: Restaurants stocks see good demand; Apex Frozen hits lower circuitFour debutantes received a mixed response on Dalal Street. Devyani International and Exxaro Tiles gave decent gains on day one, whereas Win...
- 3 out of 4 stocks make dull debut on Dalal Street: Is the IPO party over?Astha Jain of Hem Securities suggested that investors should book partial profits in Krsnaa Diagnostics and Exxaro Tiles.
- Windlas Biotech lists at 5% discount to issue priceThe IPO by the Dehradun-based pharma formulations company ran from August 4 to August 6 and was sold in the Rs 448-460 range.
- IPO grey market getting its mojo back after BSE clarificationPremia of these listing candidates in the unofficial market were hammered badly after sentiment in the second rung stocks took a hit, subsc...
- Windlas Biotech IPO: Here's how to check allotment statusThe three-day IPO received bids for 13,77,39,750 shares against 61,36,252 shares on offer, as per NSE data.
- IPO frenzy: Investors pour in Rs 1.71 lakh crore into four issuesThe ₹1,838-crore issue of Devyani International, the operator of quick-service restaurants (QSRs) such as KFC, Costa Coffee and Pizza Hut, ...
- Windlas Biotech IPO subscribed 23.68 times on Day 3The company has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according ...
- Crowding of IPOs cuts grey market premia; listing candidates lose mostLarger issues like Devyani International is commanding a premium of 70-75 per cent, or Rs 63-65, over its price band of Rs 86-90, whereas K...
- Windlas Biotech IPO subscribed 7 times on Day 2Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...
- IPO Street’s paved with gold? Retail investors can’t stop buyingThe average listing day gains of five IPOs in July was 76%. Tatva Chintan Pharma listed at a premium of 113%, GR Infraprojects rallied 109%...
- Windlas Biotech IPO sails through on day 1 of biddingThe Rs 401 crore issue received applications for 63,38,730 shares out of on-offer 61,36,252 shares, meaning a subscription of slightly over...
- Windlas Biotech offers its shares at 64x PE. Should you subscribe?The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...
- 4 IPOs going to leave you spoilt for choice: Should you go all in?They include Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech, which are going to raise close to Rs 3,614 crore ...
- 4 IPOs to keep market buzzing this week; to raise Rs 3,600 croreAnalysts and traders expect the issues to sail through given the demand for fresh issues in the market. The grey market premium has also ju...
- India Inc seeks Rs 20,000 crore more in IPO seasonCompanies usually time their IPO launches based on the market sentiment and investor appetite for these share sales. Bankers said if the mo...
- Windlas Biotech files draft papers for IPOThe company is into domestic pharmaceutical formulations contract development and manufacturing business.
Load More
